Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design

The threat of a pandemic outbreak of influenza virus A H5N1 has become a major concern worldwide. The nucleoprotein (NP) of the virus binds the RNA genome and acts as a key adaptor between the virus and the host cell. It, therefore, plays an important structural and functional role and represents an...

Full description

Saved in:
Bibliographic Details
Published inThe FASEB journal Vol. 22; no. 10; pp. 3638 - 3647
Main Authors Ng, Andy Ka-Leung, Zhang, Hongmin, Tan, Kemin, Li, Zongli, Liu, Jin-huan, Chan, Paul Kay-Sheung, Li, Sui-Mui, Chan, Wood-Yee, Au, Shannon Wing-Ngor, Joachimiak, Andrzej, Walz, Thomas, Wang, Jia-Huai, Shaw, Pang-Chui
Format Journal Article
LanguageEnglish
Published United States The Federation of American Societies for Experimental Biology 01.10.2008
Subjects
Online AccessGet more information

Cover

Loading…
Abstract The threat of a pandemic outbreak of influenza virus A H5N1 has become a major concern worldwide. The nucleoprotein (NP) of the virus binds the RNA genome and acts as a key adaptor between the virus and the host cell. It, therefore, plays an important structural and functional role and represents an attractive drug target. Here, we report the 3.3-Å crystal structure of H5N1 NP, which is composed of a head domain, a body domain, and a tail loop. Our structure resolves the important linker segments (residues 397-401, 429-437) that connect the tail loop with the remainder of the molecule and a flexible, basic loop (residues 73-91) located in an arginine-rich groove surrounding Arg150. Using surface plasmon resonance, we found the basic loop and arginine-rich groove, but mostly a protruding element containing Arg174 and Arg175, to be important in RNA binding by NP. We also used our crystal structure to build a ring-shaped assembly of nine NP subunits to model the miniribonucleoprotein particle previously visualized by electron microscopy. Our study of H5N1 NP provides insight into the oligomerization interface and the RNA-binding groove, which are attractive drug targets, and it identifies the epitopes that might be used for universal vaccine development.--Ng, A. K.-L., Zhang, H., Tan, K., Li, Z., Liu, J.-h., Chan, P. K.-S., Li, S.-M., Chan, W.-Y., Au, S. W.-N., Joachimiak, A., Walz, T., Wang, J.-H., Shaw, P.-C. Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design.
AbstractList The threat of a pandemic outbreak of influenza virus A H5N1 has become a major concern worldwide. The nucleoprotein (NP) of the virus binds the RNA genome and acts as a key adaptor between the virus and the host cell. It, therefore, plays an important structural and functional role and represents an attractive drug target. Here, we report the 3.3-A crystal structure of H5N1 NP, which is composed of a head domain, a body domain, and a tail loop. Our structure resolves the important linker segments (residues 397-401, 429-437) that connect the tail loop with the remainder of the molecule and a flexible, basic loop (residues 73-91) located in an arginine-rich groove surrounding Arg150. Using surface plasmon resonance, we found the basic loop and arginine-rich groove, but mostly a protruding element containing Arg174 and Arg175, to be important in RNA binding by NP. We also used our crystal structure to build a ring-shaped assembly of nine NP subunits to model the miniribonucleoprotein particle previously visualized by electron microscopy. Our study of H5N1 NP provides insight into the oligomerization interface and the RNA-binding groove, which are attractive drug targets, and it identifies the epitopes that might be used for universal vaccine development.
The threat of a pandemic outbreak of influenza virus A H5N1 has become a major concern worldwide. The nucleoprotein (NP) of the virus binds the RNA genome and acts as a key adaptor between the virus and the host cell. It, therefore, plays an important structural and functional role and represents an attractive drug target. Here, we report the 3.3-Å crystal structure of H5N1 NP, which is composed of a head domain, a body domain, and a tail loop. Our structure resolves the important linker segments (residues 397-401, 429-437) that connect the tail loop with the remainder of the molecule and a flexible, basic loop (residues 73-91) located in an arginine-rich groove surrounding Arg150. Using surface plasmon resonance, we found the basic loop and arginine-rich groove, but mostly a protruding element containing Arg174 and Arg175, to be important in RNA binding by NP. We also used our crystal structure to build a ring-shaped assembly of nine NP subunits to model the miniribonucleoprotein particle previously visualized by electron microscopy. Our study of H5N1 NP provides insight into the oligomerization interface and the RNA-binding groove, which are attractive drug targets, and it identifies the epitopes that might be used for universal vaccine development.--Ng, A. K.-L., Zhang, H., Tan, K., Li, Z., Liu, J.-h., Chan, P. K.-S., Li, S.-M., Chan, W.-Y., Au, S. W.-N., Joachimiak, A., Walz, T., Wang, J.-H., Shaw, P.-C. Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design.
Author Li, Zongli
Wang, Jia-Huai
Tan, Kemin
Chan, Paul Kay-Sheung
Au, Shannon Wing-Ngor
Joachimiak, Andrzej
Shaw, Pang-Chui
Walz, Thomas
Zhang, Hongmin
Li, Sui-Mui
Chan, Wood-Yee
Ng, Andy Ka-Leung
Liu, Jin-huan
Author_xml – sequence: 1
  fullname: Ng, Andy Ka-Leung
– sequence: 2
  fullname: Zhang, Hongmin
– sequence: 3
  fullname: Tan, Kemin
– sequence: 4
  fullname: Li, Zongli
– sequence: 5
  fullname: Liu, Jin-huan
– sequence: 6
  fullname: Chan, Paul Kay-Sheung
– sequence: 7
  fullname: Li, Sui-Mui
– sequence: 8
  fullname: Chan, Wood-Yee
– sequence: 9
  fullname: Au, Shannon Wing-Ngor
– sequence: 10
  fullname: Joachimiak, Andrzej
– sequence: 11
  fullname: Walz, Thomas
– sequence: 12
  fullname: Wang, Jia-Huai
– sequence: 13
  fullname: Shaw, Pang-Chui
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18614582$$D View this record in MEDLINE/PubMed
BookMark eNo10MlOwzAUhWELgWgL7FiDH4DAvU7sOOyqikmqisSwrjwWV6ldOQkCnh5EYXU2n87in5D9mKIj5BThEqERV359CbJAZIiwR8bISyiEFLBPxiAbVghRyhGZdN0aABBQHJIRSoEVl2xMPp77PJh-yI4mT_s3R0P07eDil6LvIQ8dndJ7vkAaB9O6tM2pdyFe07DZtsGoPqTYUZ8yfVpMqQ7Rhri6oKkNq7RxOXz9iguqoqXvypgQHbWuC6t4TA68ajt38rdH5OX25mV2X8wf7x5m03lhuKygsNaU6JpaaF57ry1jQpZlU1ngvpHeMNBGW21q5YRAXdcCdGVMozlyMIwdkbPd7XbQG2eX2xw2Kn8u_wv8gPMd8Cot1SqHbvn6zABLQF7VTcnZNysUaX8
CitedBy_id crossref_primary_10_1016_j_virol_2010_10_001
crossref_primary_10_1007_s13238_012_2087_5
crossref_primary_10_1038_s41598_017_13784_4
crossref_primary_10_3390_ijms232113613
crossref_primary_10_1021_acs_jmedchem_8b00557
crossref_primary_10_1128_JVI_00073_12
crossref_primary_10_1371_journal_pone_0239899
crossref_primary_10_1007_s12551_017_0333_z
crossref_primary_10_7554_eLife_26910
crossref_primary_10_1016_j_febslet_2013_02_048
crossref_primary_10_1128_MMBR_00011_14
crossref_primary_10_1016_j_bbrc_2020_02_059
crossref_primary_10_1128_JVI_00583_15
crossref_primary_10_1126_science_1227270
crossref_primary_10_1093_nar_gks1181
crossref_primary_10_1128_JVI_01424_08
crossref_primary_10_1016_j_virol_2018_09_005
crossref_primary_10_1093_nar_gkae1211
crossref_primary_10_4049_jimmunol_1501565
crossref_primary_10_1016_j_virol_2012_06_016
crossref_primary_10_3389_fmicb_2017_01308
crossref_primary_10_1016_j_drudis_2012_06_002
crossref_primary_10_1128_mBio_01224_17
crossref_primary_10_3109_1040841X_2013_826177
crossref_primary_10_1371_journal_pone_0030038
crossref_primary_10_1371_journal_pone_0036415
crossref_primary_10_1016_j_vaccine_2012_09_079
crossref_primary_10_1016_j_virol_2010_01_036
crossref_primary_10_1016_j_virol_2015_06_032
crossref_primary_10_4236_wjv_2012_23017
crossref_primary_10_1093_nar_gkr985
crossref_primary_10_7554_eLife_00631
crossref_primary_10_2217_fmb_13_128
crossref_primary_10_1039_c3mb70268e
crossref_primary_10_1371_journal_pone_0149986
crossref_primary_10_1371_journal_ppat_1000491
crossref_primary_10_1016_j_virusres_2012_04_003
crossref_primary_10_1073_pnas_1314781111
crossref_primary_10_1099_vir_0_010660_0
crossref_primary_10_1073_pnas_1113107108
crossref_primary_10_1128_JVI_00825_17
crossref_primary_10_1128_mBio_01569_16
crossref_primary_10_1007_s00253_023_12433_3
crossref_primary_10_1016_j_biochi_2011_11_009
crossref_primary_10_1016_j_vaccine_2012_04_085
crossref_primary_10_1099_vir_0_055053_0
crossref_primary_10_3851_IMP2235
crossref_primary_10_1016_j_bbrc_2013_11_100
crossref_primary_10_1128_JVI_00014_12
crossref_primary_10_3390_v8090247
crossref_primary_10_4161_rna_29730
crossref_primary_10_1007_s10930_015_9601_6
crossref_primary_10_1134_S1027451016020063
crossref_primary_10_1016_j_micinf_2010_01_001
crossref_primary_10_1021_acs_jmedchem_4c01540
crossref_primary_10_1021_acs_jmedchem_9b01244
crossref_primary_10_1128_JVI_02332_14
crossref_primary_10_1089_vim_2010_0088
crossref_primary_10_1002_jmr_1004
crossref_primary_10_1038_nsmb_1779
crossref_primary_10_1093_nar_gkac410
crossref_primary_10_1128_jvi_01972_23
crossref_primary_10_1016_j_ejcb_2015_05_012
crossref_primary_10_1073_pnas_1108515108
crossref_primary_10_1517_13543776_2013_831073
crossref_primary_10_1128_JVI_02406_14
crossref_primary_10_1128_MMBR_00024_13
crossref_primary_10_1093_nar_gkab203
crossref_primary_10_1016_j_virol_2019_08_002
crossref_primary_10_3390_v16091447
crossref_primary_10_3390_v16030421
crossref_primary_10_1038_srep15055
crossref_primary_10_1128_jvi_01757_21
crossref_primary_10_1128_JVI_02474_09
crossref_primary_10_1371_journal_ppat_1004826
crossref_primary_10_1371_journal_ppat_1003624
crossref_primary_10_1126_science_1228172
crossref_primary_10_1111_cmi_12679
crossref_primary_10_1126_sciadv_adl6144
crossref_primary_10_1586_erv_10_52
crossref_primary_10_1016_j_virol_2008_11_048
crossref_primary_10_1128_JVI_00695_11
crossref_primary_10_1038_srep29684
crossref_primary_10_1016_j_virol_2017_03_015
crossref_primary_10_1371_journal_pbio_3000008
crossref_primary_10_1128_JVI_02562_10
crossref_primary_10_1073_pnas_1200808109
crossref_primary_10_1371_journal_pone_0191226
crossref_primary_10_1038_s41598_017_17458_z
crossref_primary_10_1016_j_virol_2015_03_018
crossref_primary_10_1038_ncomms2589
crossref_primary_10_1016_j_meegid_2015_06_030
crossref_primary_10_1016_j_virusres_2013_05_010
crossref_primary_10_1038_ncomms4259
crossref_primary_10_1007_s13238_013_3901_4
crossref_primary_10_1073_pnas_1107906108
crossref_primary_10_1371_journal_ppat_1000462
crossref_primary_10_1128_JVI_01861_18
crossref_primary_10_3390_v4102137
crossref_primary_10_1002_pro_70093
crossref_primary_10_1371_journal_ppat_1006288
crossref_primary_10_1016_j_aca_2018_11_055
crossref_primary_10_1016_j_bbrc_2014_12_092
crossref_primary_10_1128_jvi_00205_22
crossref_primary_10_1002_rmv_666
crossref_primary_10_3390_v12080834
crossref_primary_10_1080_07391102_2014_979230
crossref_primary_10_1038_s41423_022_00862_5
crossref_primary_10_1517_17460441_2012_674510
crossref_primary_10_1002_med_21401
crossref_primary_10_1016_j_virol_2010_12_040
crossref_primary_10_1021_acsinfecdis_7b00120
crossref_primary_10_1016_j_tim_2014_04_001
crossref_primary_10_1002_jmv_23812
crossref_primary_10_1016_j_chemphys_2017_11_005
crossref_primary_10_1128_JVI_01634_08
crossref_primary_10_1016_j_vetmic_2010_02_032
crossref_primary_10_1016_j_virol_2016_05_018
crossref_primary_10_1016_j_tim_2013_07_006
crossref_primary_10_3390_biomedicines12112530
crossref_primary_10_1128_JVI_00997_18
crossref_primary_10_2217_fvl_14_45
crossref_primary_10_1007_s11427_009_0064_x
crossref_primary_10_1371_journal_pone_0137802
crossref_primary_10_1093_nar_gkaf112
crossref_primary_10_3389_fmicb_2022_869406
crossref_primary_10_1371_journal_ppat_1005062
crossref_primary_10_3389_fphy_2017_00025
crossref_primary_10_1016_j_virol_2014_01_023
crossref_primary_10_1101_cshperspect_a038398
crossref_primary_10_1128_AAC_02335_12
crossref_primary_10_1038_srep19063
crossref_primary_10_1093_nar_gkac688
crossref_primary_10_1128_JVI_05503_11
crossref_primary_10_1371_journal_ppat_1011214
crossref_primary_10_3390_v2010027
crossref_primary_10_3390_v10100522
crossref_primary_10_3390_vaccines10122066
crossref_primary_10_1128_JVI_02048_18
crossref_primary_10_4161_rna_8_2_14513
crossref_primary_10_1371_journal_pone_0173582
crossref_primary_10_1016_j_intimp_2011_08_019
crossref_primary_10_1111_j_1750_2659_2012_00335_x
crossref_primary_10_1073_pnas_1306838110
crossref_primary_10_1128_mbio_03315_21
crossref_primary_10_1038_nrmicro_2016_87
crossref_primary_10_1517_17460441_2015_1019859
crossref_primary_10_1016_j_antiviral_2013_07_018
crossref_primary_10_1099_vir_0_017608_0
crossref_primary_10_1371_journal_ppat_1003279
crossref_primary_10_1107_S2053230X2100635X
crossref_primary_10_1038_s41564_020_0675_3
crossref_primary_10_1371_journal_ppat_1003275
crossref_primary_10_1021_ac2022426
crossref_primary_10_3390_v16020316
crossref_primary_10_1016_j_ejphar_2017_05_038
crossref_primary_10_1007_s13238_015_0163_3
crossref_primary_10_1128_mBio_00467_12
crossref_primary_10_1016_j_abb_2012_09_006
crossref_primary_10_3390_v14030521
crossref_primary_10_1016_j_virol_2014_06_033
crossref_primary_10_1021_jacs_3c07325
crossref_primary_10_1016_j_mib_2011_07_011
crossref_primary_10_1074_jbc_M112_392878
crossref_primary_10_1128_JVI_00971_21
crossref_primary_10_2222_jsv_59_1
crossref_primary_10_1002_jmv_28968
crossref_primary_10_1016_j_vaccine_2015_09_038
crossref_primary_10_1016_j_str_2024_04_016
crossref_primary_10_3389_fimmu_2022_878943
crossref_primary_10_1016_j_tips_2009_03_002
crossref_primary_10_1038_s41598_018_37306_y
crossref_primary_10_3390_vaccines9070739
ContentType Journal Article
DBID FBQ
CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1096/fj.08-112110
DatabaseName AGRIS
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod no_fulltext_linktorsrc
Discipline Biology
EISSN 1530-6860
EndPage 3647
ExternalDocumentID 18614582
US201301547935
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GroupedDBID ---
-DZ
-~X
.55
0R~
0VX
123
18M
1OB
1OC
29H
2WC
33P
34G
39C
3O-
4.4
53G
5GY
5RE
85S
AAHHS
AANLZ
ABCUV
ABDNZ
ABEFU
ABJNI
ABOCM
ABPTK
ACCFJ
ACCZN
ACGFS
ACIWK
ACNCT
ACPOU
ACPRK
ACXQS
ACYGS
ADKYN
ADZMN
AEEZP
AEIGN
AENEX
AEQDE
AEQTP
AEUYR
AFDAS
AFFNX
AFFPM
AFMIJ
AFRAH
AGCDD
AI.
AIURR
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMYDB
BFHJK
C1A
CS3
DCZOG
DU5
D~5
E3Z
EBS
EJD
F20
F5P
F9R
FBQ
FRP
HZ~
H~9
J5H
L7B
LATKE
LEEKS
MEWTI
MVM
NEJ
O9-
OHT
OVD
Q-A
RHF
RHI
RJQFR
ROL
SAMSI
SJN
SUPJJ
TEORI
TFA
TR2
TWZ
VH1
W8F
WH7
WHG
WOQ
WXSBR
X7M
XJT
XOL
XSW
Y6R
YBU
YCJ
YHG
YKV
YNH
YSK
Z0Y
ZA5
ZCA
ZE2
ZGI
ZXP
~KM
AAHQN
AAMMB
AAMNL
AAYCA
ADXHL
AEFGJ
AEYWJ
AFWVQ
AGHNM
AGXDD
AGYGG
AHBTC
AIDQK
AIDYY
AITYG
AIZAD
ALVPJ
BIYOS
CGR
CUY
CVF
ECM
EIF
H13
HGLYW
NPM
U18
ID FETCH-LOGICAL-c5840-ddc31e976b57ffbd22683394d05f98fc20bcbdbc7ae661b7760b4cc9b5150c22
ISSN 0892-6638
IngestDate Mon Jul 21 06:02:40 EDT 2025
Wed Dec 27 19:19:12 EST 2023
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c5840-ddc31e976b57ffbd22683394d05f98fc20bcbdbc7ae661b7760b4cc9b5150c22
OpenAccessLink http://doi.org/10.1096/fj.08-112110
PMID 18614582
PageCount 10
ParticipantIDs pubmed_primary_18614582
fao_agris_US201301547935
PublicationCentury 2000
PublicationDate October 2008
PublicationDateYYYYMMDD 2008-10-01
PublicationDate_xml – month: 10
  year: 2008
  text: October 2008
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The FASEB journal
PublicationTitleAlternate FASEB J
PublicationYear 2008
Publisher The Federation of American Societies for Experimental Biology
Publisher_xml – name: The Federation of American Societies for Experimental Biology
References 4328417 - J Virol. 1971 Jul;8(1):66-73
16011865 - Vaccine. 2005 Nov 16;23(46-47):5404-10
11306552 - EMBO Rep. 2001 Apr;2(4):313-7
16424302 - Science. 2006 Jan 20;311(5759):315-6
11875246 - Bull Hist Med. 2002 Spring;76(1):105-15
16731941 - J Virol. 2006 Jun;80(12):6024-32
16704803 - Emerg Infect Dis. 2006 Apr;12(4):569-74
15103397 - Biol Proced Online. 2004;6:23-34
15572765 - Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
8035510 - J Virol. 1994 Aug;68(8):5108-16
18209073 - J Immunol. 2008 Feb 1;180(3):1758-68
9757107 - Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21
8474171 - J Virol. 1993 May;67(5):2723-9
15299374 - Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3
11907320 - J Gen Virol. 2002 Apr;83(Pt 4):723-34
10438825 - J Virol. 1999 Sep;73(9):7357-67
16844985 - Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W173-6
17623082 - Virol J. 2007;4:72
17151603 - Nature. 2006 Dec 21;444(7122):1078-82
16855301 - Acta Crystallogr D Biol Crystallogr. 2006 Aug;62(Pt 8):859-66
15163496 - Virus Res. 2004 Jul;103(1-2):97-100
16778023 - Science. 2006 Jul 21;313(5785):360-3
10405371 - Virology. 1999 Jul 20;260(1):190-200
18332179 - J Exp Med. 2008 Mar 17;205(3):711-23
14749182 - Virus Res. 2004 Feb;99(2):169-75
10590102 - J Virol. 2000 Jan;74(1):156-63
18353950 - J Virol. 2008 Jun;82(11):5161-6
16837112 - Vaccine. 2006 Nov 10;24(44-46):6594-6
7966640 - J Virol. 1994 Dec;68(12):8433-6
17176120 - BioDrugs. 2006;20(6):335-40
8806539 - Virology. 1996 Sep 1;223(1):51-6
8039508 - EMBO J. 1994 Jul 1;13(13):3158-65
1824905 - Virology. 1991 Feb;180(2):668-77
16778022 - Science. 2006 Jul 21;313(5785):357-60
9135141 - EMBO J. 1997 Mar 17;16(6):1248-57
9621005 - J Virol. 1998 Jul;72(7):5493-501
14691253 - Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):308-13
16103176 - J Virol. 2005 Sep;79(17):11239-46
12399202 - Vaccine. 2002 Nov 1;20(31-32):3731-8
References_xml – reference: 16011865 - Vaccine. 2005 Nov 16;23(46-47):5404-10
– reference: 8474171 - J Virol. 1993 May;67(5):2723-9
– reference: 11875246 - Bull Hist Med. 2002 Spring;76(1):105-15
– reference: 17176120 - BioDrugs. 2006;20(6):335-40
– reference: 11306552 - EMBO Rep. 2001 Apr;2(4):313-7
– reference: 14691253 - Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):308-13
– reference: 16731941 - J Virol. 2006 Jun;80(12):6024-32
– reference: 9135141 - EMBO J. 1997 Mar 17;16(6):1248-57
– reference: 16837112 - Vaccine. 2006 Nov 10;24(44-46):6594-6
– reference: 16704803 - Emerg Infect Dis. 2006 Apr;12(4):569-74
– reference: 17623082 - Virol J. 2007;4:72
– reference: 8039508 - EMBO J. 1994 Jul 1;13(13):3158-65
– reference: 8035510 - J Virol. 1994 Aug;68(8):5108-16
– reference: 15572765 - Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
– reference: 15299374 - Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3
– reference: 16424302 - Science. 2006 Jan 20;311(5759):315-6
– reference: 11907320 - J Gen Virol. 2002 Apr;83(Pt 4):723-34
– reference: 18209073 - J Immunol. 2008 Feb 1;180(3):1758-68
– reference: 9757107 - Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21
– reference: 15103397 - Biol Proced Online. 2004;6:23-34
– reference: 9621005 - J Virol. 1998 Jul;72(7):5493-501
– reference: 17151603 - Nature. 2006 Dec 21;444(7122):1078-82
– reference: 10590102 - J Virol. 2000 Jan;74(1):156-63
– reference: 16778023 - Science. 2006 Jul 21;313(5785):360-3
– reference: 16855301 - Acta Crystallogr D Biol Crystallogr. 2006 Aug;62(Pt 8):859-66
– reference: 18353950 - J Virol. 2008 Jun;82(11):5161-6
– reference: 10405371 - Virology. 1999 Jul 20;260(1):190-200
– reference: 16778022 - Science. 2006 Jul 21;313(5785):357-60
– reference: 10438825 - J Virol. 1999 Sep;73(9):7357-67
– reference: 14749182 - Virus Res. 2004 Feb;99(2):169-75
– reference: 12399202 - Vaccine. 2002 Nov 1;20(31-32):3731-8
– reference: 8806539 - Virology. 1996 Sep 1;223(1):51-6
– reference: 16844985 - Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W173-6
– reference: 7966640 - J Virol. 1994 Dec;68(12):8433-6
– reference: 16103176 - J Virol. 2005 Sep;79(17):11239-46
– reference: 18332179 - J Exp Med. 2008 Mar 17;205(3):711-23
– reference: 1824905 - Virology. 1991 Feb;180(2):668-77
– reference: 4328417 - J Virol. 1971 Jul;8(1):66-73
– reference: 15163496 - Virus Res. 2004 Jul;103(1-2):97-100
SSID ssj0001016
Score 2.3812242
Snippet The threat of a pandemic outbreak of influenza virus A H5N1 has become a major concern worldwide. The nucleoprotein (NP) of the virus binds the RNA genome and...
SourceID pubmed
fao
SourceType Index Database
Publisher
StartPage 3638
SubjectTerms Amino Acid Sequence
Antiviral Agents - chemistry
Antiviral Agents - pharmacology
Crystallography, X-Ray
Drug Design
Influenza A Virus, H5N1 Subtype - chemistry
Influenza A Virus, H5N1 Subtype - drug effects
Influenza A Virus, H5N1 Subtype - immunology
Influenza Vaccines - chemistry
Influenza Vaccines - immunology
Molecular Sequence Data
Nucleoproteins - chemistry
Nucleoproteins - drug effects
Nucleoproteins - immunology
Protein Conformation
RNA - chemistry
Viral Core Proteins - chemistry
Viral Core Proteins - drug effects
Viral Core Proteins - immunology
Title Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design
URI https://www.ncbi.nlm.nih.gov/pubmed/18614582
Volume 22
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZaEBIviPvGZfIDb1lGmnt469Cqio1K0E6aeKlix64ysWSCdWL7H_xfPl_SeuUi4CWq7CaxfL743M8h5BUHVyhkGvuJrBI_TuPCz0PJ_aiMRZonaRXr_Ir3k3R8HL87SU56ve9O1NLygu3x61_mlfwPVTEGuqos2X-g7OqhGMBv0BdXUBjXv6LxVBd_VS4A6-mvTcuR69K7rL8sv-KrHyeTgdeoosWtLslQ60iO2o0jV4GGHydDj9U6w0Vtevu5XrTKl2OSNLsQz8uSKz-8V63DPk7XaBsNpwf7nrtwZWRe2LDJK--w9I_E0nJK11Y9bpvFWb2OCDY22UPhjB3poINPrUo6vmGoyFchb-Az3eEKVTU3_QO60zcMXZQFzlkapabuy0-HPLQuRZnTPfUOVaIucP-GXTw_0wQf5JA9EtPb6M-zGyW3u6k-6UP5UN1UlQnIsndl7rAZFFjIa3cZqgKtvRWiiizbDV1Fyyyz--SeVTbo0CDnAemJ5iG5Y9qPXj0i31b4oa2kwA9d4Ydq_NAhVfihN_DzhrrooUAPBXqoRc8u3cDOLgVyqEUONch5TGajg9nbsW87cfgcAmrgVxWPBgKSK0syKVkFmT2PoiKugkQWueRhwDirGM9KAXmPZVkasJjzgkFaDngYPiG3mrYRW4QOBgw6aZZBMZE4JQrGSyFLDq1fpEJW-TbZwr7NywVY3Px4GirHOqR8cJFkmzw1mzk_N4VY5t1mP_vtzHNydw3FF-S2xJcvXkKMvGA7pD_a_7CjifsDG4xxTw
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Structure+of+the+influenza+virus+A+H5N1+nucleoprotein%3A+implications+for+RNA+binding%2C+oligomerization%2C+and+vaccine+design&rft.jtitle=The+FASEB+journal&rft.au=Ng%2C+Andy+Ka-Leung&rft.au=Zhang%2C+Hongmin&rft.au=Tan%2C+Kemin&rft.au=Li%2C+Zongli&rft.date=2008-10-01&rft.eissn=1530-6860&rft.volume=22&rft.issue=10&rft.spage=3638&rft_id=info:doi/10.1096%2Ffj.08-112110&rft_id=info%3Apmid%2F18614582&rft_id=info%3Apmid%2F18614582&rft.externalDocID=18614582
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0892-6638&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0892-6638&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0892-6638&client=summon